Go Pro
NYSE:TDOC

Teladoc Health Q2 2026 Earnings Report

Teladoc Health logo
$9.19 -0.01 (-0.11%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$9.06 -0.13 (-1.36%)
As of 07/2/2026 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Teladoc Health EPS Results

Actual EPS
N/A
Consensus EPS
-$0.24
Beat/Miss
N/A
One Year Ago EPS
N/A

Teladoc Health Revenue Results

Actual Revenue
N/A
Expected Revenue
$614.80 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Teladoc Health Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Tuesday, July 28, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

Teladoc Health Earnings Headlines

SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. Elon believes what Michael Robinson calls 'Project Unlimited' could unlock $100 trillion in potential growth. One little-known company sits at the center of it all, and most investors have no idea it exists. Position yourself before this company potentially hits the front page.tc pixel
1 Value Stock with Solid Fundamentals and 2 We Question
See More Teladoc Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Teladoc Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Teladoc Health and other key companies, straight to your email.

About Teladoc Health

Teladoc Health (NYSE:TDOC) is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease. The company also provides integrated virtual care solutions that combine live consultations with remote patient monitoring devices, enabling continuous health tracking and proactive intervention. In 2020, Teladoc expanded its capabilities through the acquisition of Livongo Health, a leader in digital chronic condition management, thereby strengthening its population health offerings.

With headquarters in Purchase, New York, Teladoc operates in more than 175 countries and serves a diverse client base that includes employers, health plans, hospitals, and health systems. The company maintains regional operations in North America, Latin America, Europe, and the Asia Pacific region, adapting services to meet local regulatory requirements and healthcare needs. Strategic partnerships with insurers and healthcare providers help Teladoc integrate virtual care into existing care pathways and insurance networks.

Founded in 2002 by Michael Gorton and Byron Brooks, Teladoc has evolved from a telephonic medical consultation service into a comprehensive virtual care platform. Jason Gorevic has served as Chief Executive Officer since 2009, guiding the company through rapid expansion, technology innovation, and multiple acquisitions. Under his leadership, Teladoc continues to invest in digital health solutions, artificial intelligence, and data-driven tools to support the future of connected care.

View Teladoc Health Profile